Yunkang Group Limited (HKG:2325)

Market Cap	327.79M -52.9%
Revenue (ttm)	624.49M -16.2%
Net Income	70.08M
EPS	0.12
Shares Out	585.34M
PE Ratio	4.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	420,000
Open	0.5900
Previous Close	0.5850
Day's Range	0.5500 - 0.5950
52-Week Range	0.4400 - 1.2500
Beta	-0.72
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Yunkang Group

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic test...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 1,008
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2325

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error